Canaf Investments Inc. (TSXV:CAF)

Checkpoint Therapeutics Income Statement

Financials in millions CAD. Fiscal year is November - October.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 30, 2025	Oct 31, 2024	Oct 31, 2023	Oct 31, 2022	Oct 31, 2021	Oct 31, 2020
Revenue	30.68	32.72	32.33	22.2	17.61	18.02
Revenue Growth (YoY)	-12.77%	1.22%	45.63%	26.03%	-2.26%	16.54%
Cost of Revenue	26.94	29.19	28.38	19.85	15.65	15.88
Gross Profit	3.74	3.53	3.94	2.35	1.96	2.14
Selling, General & Admin	0.91	0.89	0.91	0.72	0.63	0.68
Operating Expenses	0.91	0.89	0.91	0.72	0.63	0.68
Operating Income	2.83	2.65	3.04	1.63	1.33	1.46
Interest & Investment Income	1	0.76	0.52	0.26	0.22	0.2
Currency Exchange Gain (Loss)	0	-0	-0	-0	0.01	-0
Other Non Operating Income (Expenses)	-0.02	-0.03	-0	0.03	0.03	-0
EBT Excluding Unusual Items	3.82	3.37	3.56	1.92	1.59	1.66
Gain (Loss) on Sale of Assets	-	-	-	0.04	0.01	-
Pretax Income	3.82	3.37	3.56	1.96	1.6	1.66
Income Tax Expense	0.96	0.88	0.62	0.57	0.43	0.47
Earnings From Continuing Operations	2.86	2.49	2.94	1.39	1.17	1.19
Minority Interest in Earnings	-0.39	-0.33	-0.7	-0.36	-0.27	-0.29
Net Income	2.46	2.16	2.24	1.03	0.9	0.91
Net Income to Common	2.46	2.16	2.24	1.03	0.9	0.91
Net Income Growth	7.76%	-3.44%	117.40%	14.63%	-0.81%	75.38%
Shares Outstanding (Basic)	47	47	47	47	47	47
Shares Outstanding (Diluted)	47	47	47	47	47	47
EPS (Basic)	0.05	0.05	0.05	0.02	0.02	0.02
EPS (Diluted)	0.05	0.05	0.05	0.02	0.02	0.02
EPS Growth	7.76%	-3.44%	117.40%	14.64%	-0.81%	75.38%
Free Cash Flow	3.89	3.16	2.05	1.83	1.46	2.7
Free Cash Flow Per Share	0.08	0.07	0.04	0.04	0.03	0.06
Gross Margin	12.19%	10.80%	12.20%	10.59%	11.12%	11.89%
Operating Margin	9.23%	8.09%	9.40%	7.36%	7.57%	8.13%
Profit Margin	8.03%	6.60%	6.92%	4.64%	5.10%	5.03%
Free Cash Flow Margin	12.66%	9.66%	6.33%	8.23%	8.27%	15.01%
EBITDA	3.05	2.83	3.25	1.85	1.56	1.72
EBITDA Margin	9.93%	8.66%	10.04%	8.33%	8.86%	9.55%
D&A For EBITDA	0.21	0.19	0.21	0.22	0.23	0.26
EBIT	2.83	2.65	3.04	1.63	1.33	1.46
EBIT Margin	9.23%	8.09%	9.40%	7.36%	7.57%	8.13%
Effective Tax Rate	25.14%	26.21%	17.47%	29.03%	26.88%	28.12%
Revenue as Reported	32.72	32.72	32.33	-	-	-
Advertising Expenses	-	0	0	0	0.01	0

Source: S&P Global Market Intelligence. Standard template. Financial Sources.